AB-1005 gene therapy placed on fast track by regulators in US, UK
AskBio’s investigational gene therapy AB-1005 has been granted fast-track designation for Parkinson’s disease by the U.S. Food and Drug Administration (FDA), and innovation passport designation… Weiterlesen »AB-1005 gene therapy placed on fast track by regulators in US, UK